Compare PCVX & WFRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | WFRD |
|---|---|---|
| Founded | 2013 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 7.8B |
| IPO Year | 2020 | 2014 |
| Metric | PCVX | WFRD |
|---|---|---|
| Price | $49.89 | $108.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $88.25 | ★ $103.22 |
| AVG Volume (30 Days) | ★ 1.6M | 1.0M |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.49 |
| Revenue | N/A | ★ $4,331,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.22 |
| P/E Ratio | ★ N/A | $72.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.10 | $42.75 |
| 52 Week High | $65.00 | $113.15 |
| Indicator | PCVX | WFRD |
|---|---|---|
| Relative Strength Index (RSI) | 39.93 | 54.84 |
| Support Level | $42.30 | $101.35 |
| Resistance Level | $56.04 | $112.01 |
| Average True Range (ATR) | 2.47 | 3.67 |
| MACD | -0.51 | -0.22 |
| Stochastic Oscillator | 34.37 | 61.27 |
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Weatherford provides oilfield services and equipment to national, integrated, public, and private oil and gas operators. It operates across multiple upstream markets, including offshore, the rest of the world onshore, and US onshore, where Weatherford has limited exposure. The Middle East, North Africa, and Asia account for over 25% of sales. Weatherford also offers manufacturing, research, and training services. Performance is reported through three segments: drilling and evaluation, well construction and completions, and production and intervention.